These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722 [Abstract] [Full Text] [Related]
25. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Kim YH, Park SW, Lee CW, Hong MK, Gwon HC, Jang Y, Lee MM, Koo BK, Oh DJ, Seung KB, Tahk SJ, Yoon J, Park SJ. Catheter Cardiovasc Interv; 2006 Feb 15; 67(2):181-7. PubMed ID: 16400663 [Abstract] [Full Text] [Related]
27. Long-term outcomes comparison of different types of DES in elderly patients from a real-world experience. Sanfilippo A, Cumbo M, Caggegi AM, Monaco S, Bucalo R, Ruperto C, Tamburino C, Ussia GP, Galassi AR, Capranzano P, Capodanno D, Tamburino C. J Invasive Cardiol; 2009 Jul 15; 21(7):330-3. PubMed ID: 19571343 [Abstract] [Full Text] [Related]
28. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. J Invasive Cardiol; 2006 Dec 15; 18(12):577-83. PubMed ID: 17197706 [Abstract] [Full Text] [Related]
29. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry. Akin I, Bufe A, Eckardt L, Reinecke H, Richardt G, Kuck KH, Senges J, Schneider S, Nienaber CA, DES.DE Study Group. Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):50-7. PubMed ID: 20578192 [Abstract] [Full Text] [Related]
30. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW, Interventional Cardiologists of the Thoraxcenter. JACC Cardiovasc Interv; 2010 Oct 01; 3(10):1051-8. PubMed ID: 20965464 [Abstract] [Full Text] [Related]
36. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry. Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, Gai LY, Ge JB, Wang WM, Du ZM, Huo Y, Wang LF, Gao W, Chen JY, He B, Jia GL, Yang ZJ, Cao KJ, Li WM, Shen WF, Wan Z, Huang DJ, Zhu GY, CCSR Investigators. Int J Cardiol; 2008 Apr 25; 125(3):339-46. PubMed ID: 17434617 [Abstract] [Full Text] [Related]
37. Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials. Qian J, Chen Z, Ma J, Ge J. Catheter Cardiovasc Interv; 2012 Oct 01; 80(4):507-13. PubMed ID: 22045690 [Abstract] [Full Text] [Related]
40. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Roy P, Bonello L, de Labriolle A, Okabe T, Pinto Slottow TL, Steinberg DH, Torguson R, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Am J Cardiol; 2008 Aug 01; 102(3):292-7. PubMed ID: 18638589 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]